Hydroxyzine embonate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H27ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30S50YM8OG, chemically known as ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)- but generally known as hydroxyzine, which bears US NIH Compound Identifier 3658. European Medicines Agency schedules Hydroxyzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08088MIG. The term HYDROXYZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules hydroxyzine in its Anatomical Therapeutic Chemical (ATC) Classification. HYDROXYZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hydroxyzine embonate under HS 29335995 and SITC 51576. SMILES: CLC1CCC(C(N2CCN(CC2)CCOCCO)C2CCCCC2)CC1.